Dodge & Cox’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.06B | Sell |
|
|||||
|
2025
Q2 | $1.04B | Sell |
|
|||||
|
2025
Q1 | $905M | Sell |
|
|||||
|
2024
Q4 | $833M | Sell |
|
|||||
|
2024
Q3 | $996M | Sell |
|
|||||
|
2024
Q2 | $919M | Sell |
|
|||||
|
2024
Q1 | $570M | Buy |
|
|||||
|
2023
Q4 | $703M | Sell |
|
|||||
|
2023
Q3 | $664M | Sell |
|
|||||
|
2023
Q2 | $720M | Sell |
|
|||||
|
2023
Q1 | $780M | Sell |
|
|||||
|
2022
Q4 | $1.09B | Sell |
|
|||||
|
2022
Q3 | $979M | Sell |
|
|||||
|
2022
Q2 | $767M | Sell |
|
|||||
|
2022
Q1 | $894M | Buy |
|
|||||
|
2021
Q4 | $921M | Buy |
|
|||||
|
2021
Q3 | $1.01B | Sell |
|
|||||
|
2021
Q2 | $918M | Buy |
|
|||||
|
2021
Q1 | $610M | Sell |
|
|||||
|
2020
Q4 | $603M | Sell |
|
|||||
|
2020
Q3 | $681M | Sell |
|
|||||
|
2020
Q2 | $697M | Sell |
|
|||||
|
2020
Q1 | $554M | Sell |
|
|||||
|
2019
Q4 | $605M | Sell |
|
|||||
|
2019
Q3 | $427M | Buy |
|
|||||
|
2019
Q2 | $380M | Buy |
|
|||||
|
2019
Q1 | $467M | Buy |
|
|||||
|
2018
Q4 | $342M | Buy |
|
|||||
|
2018
Q3 | $407M | Buy |
|
|||||
|
2018
Q2 | $458M | Sell |
|
|||||
|
2018
Q1 | $559M | Sell |
|
|||||
|
2017
Q4 | $1.05B | Sell |
|
|||||
|
2017
Q3 | $1.07B | Sell |
|
|||||
|
2017
Q2 | $733M | Sell |
|
|||||
|
2017
Q1 | $482M | Buy |
|
|||||
|
2016
Q4 | $345M | Buy |
|
|||||
|
2016
Q3 | $358M | Buy |
|
|||||
|
2016
Q2 | $140M | Buy |
|